Amy Rommel
-
- Circadian rhythm and melatonin 1
- Aging top 5%
- Toxicology top 5%
- Bioactive Compounds and Antitumor Agents 1
-
- Glioma Diagnosis and Treatment 2
-
- Cancer, Hypoxia, and Metabolism 1
-
- DNA Repair Mechanisms 2
- Epigenetics and DNA Methylation 2
- Cancer therapeutics and mechanisms 1
- CRISPR and Genetic Engineering 1
- Co-authors
- Inder M. VermaMatthew J. KolarSatchidananda PandaFrancesca PucaXiaojie WangGabriele SulliAlan SaghatelianMaksim V. Plikus
- Partner nations
- United StatesCanadaSwitzerland
In The Last Decade
Amy Rommel
7 papers receiving 548 citations
Hit Papers
Peers
Comparison fields: 5 of 76
- Endocrine and Autonomic Systems 192
- Aging 41
- Toxicology 67
- Genetics 62
- Cancer Research 85
Countries citing papers authored by Amy Rommel
This map shows the geographic impact of Amy Rommel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Rommel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Rommel more than expected).
Fields of papers citing papers by Amy Rommel
This network shows the impact of papers produced by Amy Rommel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Rommel. The network helps show where Amy Rommel may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Amy Rommel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 12 | |
| 2 | Pharmacological activation of REV-ERBs is lethal in cancer and oncogene-induced senescencebreakdown → | 2018 | 288 |
| 3 | 2017 | 25 | |
| 4 | 2014 | 38 | |
| 5 | 2014 | 2 | |
| 6 | 2013 | 84 | |
| 7 | 2013 | 110 |
About Amy Rommel
Amy Rommel is a scholar working on Toxicology, Genetics and Endocrine and Autonomic Systems, having authored 7 papers that have together received 559 indexed citations. Recurring topics across this work include DNA Repair Mechanisms (2 papers), Glioma Diagnosis and Treatment (2 papers), Epigenetics and DNA Methylation (2 papers), Bioactive Compounds and Antitumor Agents (1 paper), Cancer therapeutics and mechanisms (1 paper), CRISPR and Genetic Engineering (1 paper), Cancer, Hypoxia, and Metabolism (1 paper) and Circadian rhythm and melatonin (1 paper). The work is most often cited by research in Endocrine and Autonomic Systems (192 citations), Aging (41 citations) and Toxicology (67 citations). Amy Rommel has collaborated with scholars based in United States, Canada and Switzerland. Frequent co-authors include Inder M. Verma, Matthew J. Kolar, Satchidananda Panda, Francesca Puca, Xiaojie Wang, Gabriele Sulli, Alan Saghatelian, Maksim V. Plikus, Chad Myskiw and Yasushi Soda. Their work appears in journals such as Molecular Cancer Therapeutics, Clinical Cancer Research, Nature, Nucleic Acids Research and Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.